Skip to main content
HairCited

Androgenetic alopecia.

Nina Otberg, Andreas M Finner, Jerry Shapiro
Review Endocrinology and metabolism clinics of North America 2007 33 اقتباسات
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D17543725'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

نوع الدراسة
Review
المجتمع المدروس
None
التدخل
Androgenetic alopecia. None
المقارن
None
النتيجة الأولية
Androgenetic alopecia.
اتجاه التأثير
Mixed
خطر التحيز
Unclear

Abstract

Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (eg, finasteride, minoxidil, or a combination of both), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Combination with hair restoration surgery leads to best results in suitable candidates. Physicians who specialize in male health issues should be familiar with this common condition and all the available approved treatment options.

باختصار

Physicians who specialize in male health issues should be familiar with this common condition and all the available approved treatment options.

Used In Evidence Reviews

Similar Papers